When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Arcutis Biotherapeutics (ARQT) has priced its public offering of 4M common shares at $25.00/share, for the expected gross proceeds of $100M.Underwriters' over-allotment is an additional 600K shares.Closing date is Oct. 6. Concurrently, Arcutis expects to sell to entities affiliated with OrbiMed Advisors, 1.4M common shares in a private placement, at a public offering price for expected gross proceeds of $35M.Previously: Arcutis Biotherapeutics proposes equity offering, concurrent $35M placement (Sept. 29)